World's first lung cancer vaccine trial launched

ANKARA — Physicians have launched the world's first mRNA lung cancer vaccine trial across seven countries, including Türkiye, in a groundbreaking effort that could revolutionize cancer treatment, according to press reports on Friday.

The vaccine, known as BNT116 and developed by BioNTech, is designed to target non-small cell lung cancer (NSCLC), the most common type of lung cancer.